Recombinant Human SLITRK6 Protein, CF Summary
Product Specifications
Ile16-Ala604, with a C-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
8985-SK
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: SLITRK6
SLITRK6 (Slit and Trk-like family member 6) is a type I transmembrane member of the SLITRK family of proteins which contain a slit-like extracellular region and (save for SLITRK1) a Trk-like cytoplasmic region. Mature human SLITRK6 consists of a 582 amino acid (aa) extracellular domain (ECD) with 5 leucine rich repeats (LRR) flanked by N-and C-terminal LRR domains, followed by 6 more LRR flanked by another pair of N- and C-terminal LRR domains (1, 2). Within the ECD, human SLITRK6 shares 88% aa sequence identity with mouse and rat SLITRK6. SLITRK6 is expressed in multiple regions of the developing nervous system, notably in the otic vesicle, cochlear and vestibular sensory epithelia, and spiral and vestibular ganglion neurons (3, 4). It can suppress neurite outgrowth and promote the formation of excitatory and inhibitory presynaptic structures (2, 5). Mice lacking SLITRK6 exhibit delayed retinal synaptogenesis and multiple auditory abnormalities as well as defective auditory sensory innervation, neuronal loss in the vestibular ganglia, and reduced cochlear expression of BDNF, NT-3, TrkB, and TrkC (4, 6, 7). In humans, nonsense mutations of SLITRK6 are associated with myopia and sensorial deafness (6).
- Aruga, J. et al. (2003) Gene 315:87.
- Aruga, J. and K. Mikoshiba (2003) Mol. Cell. Neurosci. 24:117.
- Aruga, J. (2003) Gene Expr. Patterns 3:727.
- Katayama, K.-I. et al. (2009) PLoS ONE 4:e7786.
- Takahashi, H. et al. (2012) Nat. Neurosci. 15:389.
- Tekin, M. et al. (2013) J. Clin. Invest. 123:2094.
- Matsumoto, Y. et al. (2011) PLoS ONE 6:e16497.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human SLITRK6 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human SLITRK6 Protein, CF and earn rewards!
Have you used Recombinant Human SLITRK6 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image